Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Crohn Disease (CD)
This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of standard-dose tumor necrosis …
Guangzhou, ChinaEst. completion Dec 31, 2028
Inflammatory Bowel Diseases (IBD)Remission of IBDIn AdultsInflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)Crohn's Disease (CD)Ulcerative Colitis (UC)
The VIBRANT-IBD study is a pilot, prospective, single-arm feasibility study investigating the effects of non-invasive va…
Gdansk, PolandCompleted Dec 15, 2026
Crohn's Disease
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to s…
Dothan, United StatesEst. completion Oct 30, 2028
Crohn's Disease
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.
Birmingham, United StatesEst. completion May 23, 2025
Crohn Disease
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to…
Anaheim, United StatesEst. completion Jun 12, 2028
Crohn's Disease
The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 an…
Dothan, United StatesEst. completion Oct 20, 2023
Moderately to Severely Active Crohns Disease
This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction t…
Glendale, United StatesEst. completion Dec 31, 2028
Ulcerative Colitis (UC)Ulcerative Colitis (Disorder)Ulcerative Colitis AcuteIBD (Inflammatory Bowel Disease)CD - Crohn's Disease
A Phase 1, 2-part, randomised, double-blind, placebo-controlled, FIH study to determine the safety, tolerability, and PK…
Hangzhou, ChinaEst. completion Dec 31, 2026
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lin…
Harrow, United KingdomEst. completion Mar 5, 2029
Crohn Disease
The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with mode…
Dothan, United StatesEst. completion Nov 15, 2028
Crohn's Disease
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tra…
Dothan, United StatesEst. completion Jan 2030
Fistulizing Crohns DiseasePerianal Crohns Disease
The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and t…
Birmingham, United StatesEst. completion Mar 25, 2027
Crohn Disease
The purpose of this study is to evaluate how well guselkumab works in participants with Crohn's disease (CD; a long-term…
Guangzhou, ChinaEst. completion Sep 15, 2027
Crohn DiseaseColitis, Ulcerative
The purpose of this study is to evaluate how long a participant keeps taking guselkumab or continues with their treatmen…
Multiple LocationsEst. completion Jun 15, 2029
Crohn Disease
The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in p…
Chandler, United StatesEst. completion Sep 19, 2028
Inflammatory Bowel DiseaseUlcerative ColitisChrohn's Disease
This study will investigate in patients with Crohn s disease and ulcerative colitis how the body s immune system control…
Bethesda, United States
Quiescent Crohn's Disease (CD)
Many individuals with Crohn's disease continue to experience abdominal pain, bloating, or bowel habit changes even when …
Ann Arbor, United StatesEst. completion Dec 2029
Crohn's Disease (CD)
Micro and nanoplastics (MNPs) are environmental contaminants found in food and water. Recent evidence suggests these par…
Hong Kong, Hong KongEst. completion Jun 30, 2031